Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Sujan
S
Ravi
Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Page
P
Axley
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
DeAnn
D
Jones
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
Sudha
S
Kodali
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
Heather
H
Simpson
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
Brendan M
BM
McGuire
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
Ashwani K
AK
Singal
D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000821:virology*; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000821:virology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents